Skip to main content
. 2015 Jan 21;9(3):880–884. doi: 10.3892/etm.2015.2196

Table I.

Association between EGFR mutations, ERCC1 and RRM1 mRNA expression, and patient clinical characteristics.

EGFR ERCC1 RRM1



Clinical features Mutant (n) Wild-type (n) P-value High (n) Low (n) P-value High (n) Low (n) P-value
Gender <0.001 0.898 0.088
 Male 52 86 65 73 92 46
 Female 74 45 57 62 67 52
Age, years 0.287 0.943 0.714
 ≥59 68 62 62 68 79 51
 <59 58 69 60 67 80 47
Smoking history <0.001 0.199 0.129
 Yes 34 65 52 47 67 32
 No 92 66 70 88 92 66
Tumor diameter, cm 0.282 0.687 0.292
 ≥5 56 67 60 63 72 51
 <5 70 64 62 72 87 47
Lymph node metastasis 0.903 0.470 0.188
 Yes 51 54 47 58 70 35
 No 75 77 75 77 89 63
Clinical stage 0.203 0.339 0.577
 I 50 42 40 52 59 33
 II+III+IV 76 89 82 83 100 65

EGFR, epidermal growth factor receptor; ERCC1, excision repair cross-complementing protein 1; RRM1, ribonucleotide reductase subunit M1.